ENDRA Life Sciences (NDRA) Return on Capital Employed Growth (1y) (2018 - 2026)
ENDRA Life Sciences (NDRA) Return on Capital Employed Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | -17.00 |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 42.00 |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 768.00 |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 44.00 |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | -18.00 |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 732.00 |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | -1,014.00 |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | -251.00 |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 109.00 |
| 10 | ENDRA Life Sciences | 7.16 Mn | 1.62 Mn | - | 21,988.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 21,988.00 |
| Mar 31, 2026 | 49,634.00 |
| Dec 31, 2025 | -563,969.00 |
| Sep 30, 2025 | -35,573.00 |
| Jun 30, 2025 | -20,555.00 |
| Mar 31, 2025 | -50,556.00 |
| Dec 31, 2024 | 554,028.00 |
| Sep 30, 2024 | 2,146.00 |
| Jun 30, 2024 | 6,411.00 |
| Mar 31, 2024 | -499.00 |
| Dec 31, 2023 | -2,314.00 |
| Sep 30, 2023 | -9,133.00 |
| Jun 30, 2023 | -10,950.00 |
| Mar 31, 2023 | -10,426.00 |
| Dec 31, 2022 | -5,290.00 |
| Sep 30, 2022 | -3,390.00 |
| Jun 30, 2022 | -3,587.00 |
| Mar 31, 2022 | -2,765.00 |
| Dec 31, 2021 | 9,767.00 |
| Sep 30, 2021 | 38,356.00 |